In another study, researchers found that the immunoregulatory drug icaritin could inhibit HCC cells proliferation via promoting immunogenic cell death (ICD) and triggering mitophagy by activating the PINK1-Parkin pathway, a classical mitophagy regulating signaling cascade. Here, PINK1 is linked to hepatocellular carcinoma.